The Philippines is the third-largest pharmaceutical market in ASEAN after Thailand and Indonesia. In 2019, total generic drug sales were in the Philippines were PHP82.3 billion, and accounts for 63% of prescription sales and estimate to reach PHP110 Billion by 2024. The highest cost of medicines in the Philippines among other ASEAN countries is one […]
Read More →The Philippines is a country with a large population and wide network of hospitals, medical centers, and health care professionals, making it a fertile platform for conducting clinical trials. In clinical trials, the Philippines ranks number three in Southeast countries (US NIH) and ranks number eight worldwide (European Medicines Agency reports). Philippines clinical trials Currently, […]
Read More →With patients with ovarian cancer as the target trial population, clinical trial feasibility was performed. The clinical trial sites/investigators, who participated in this feasibility came mainly from India, Russia, the Philippines, Vietnam, Thailand, and South Korea. What are the causes of ovarian cancer? The causes of ovarian cancer are unclear but doctors have identified factors that […]
Read More →Worldwide, breast cancer is the most common invasive cancer in women. Along with lung cancer, breast cancer is the most commonly diagnosed cancer, with 2.09 million cases each in 2018, and Breast cancer affects 1 in 7 (14%) of women worldwide. What is breast cancer? Breast cancer is a cancer that develops from breast tissue. […]
Read More →